421 results on '"Donson, Andrew M."'
Search Results
2. Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas
3. Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature
4. Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas
5. Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas
6. Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma
7. Multi-pronged analysis of pediatric low-grade glioma reveals a unique tumor microenvironment associated with BRAF alterations
8. Targeting fibroblast growth factor receptors to combat aggressive ependymoma
9. Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma
10. Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis
11. SOX10 Distinguishes Pilocytic and Pilomyxoid Astrocytomas From Ependymomas but Shows No Differences in Expression Level in Ependymomas From Infants Versus Older Children or Among Molecular Subgroups
12. Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B
13. Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile
14. Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma
15. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups
16. Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high-grade glioma.
17. Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high-grade glioma
18. Genetic Predictors of Neurocognitive Outcomes in Survivors of Pediatric Brain Tumors
19. Mapping pediatric brain tumors to their origins in the developing cerebellum
20. Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic images
21. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target
22. Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: a multicenter study
23. Data from Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion–Positive Supratentorial Ependymomas
24. Supplementary Figure Legends from Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
25. Supplementary Table S4 from Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion–Positive Supratentorial Ependymomas
26. Supplementary Figure 4 from Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
27. Data from Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
28. Supplemental Figure Legends from Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma
29. Supplementary Figure 2 from Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
30. Supplementary Figure 5 from Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma
31. Supplementary Figure 5 from Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
32. Data from Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma
33. Data from Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma
34. Supplementary Data from Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma
35. Supplementary Figure 6 from Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma
36. Supplementary Figure 1 from Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma
37. Supplementary Figure 2 from Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma
38. Supplementary Figure 3 from Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
39. Supplementary Figure 1 from Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
40. Supplementary figure 1 from Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma
41. Supplementary Figure 4 from Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma
42. Supplementary Table 1 from Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma
43. Supplementary Figure 2 from Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma
44. Supplementary Data from Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion–Positive Supratentorial Ependymomas
45. Supplementary Figure 6 from Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
46. Supplementary Figure 3 from Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma
47. Data from Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
48. Supplementary Data from Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
49. PDGFB:APOBEC3C fusion in congenital diffuse high-grade glioma of the brainstem
50. Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.